Breath sniffing tech may replace scans for mesothelioma patients

NCT ID NCT06037941

Recruiting now Diagnosis Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new breath test, called an electronic nose (E-Nose), to see if it can measure how well treatment is working for people with malignant pleural mesothelioma (MPM). Researchers will collect breath samples from 20 patients before and during standard treatment, and compare the results to CT scans and blood tests. The goal is to find a simpler, non-invasive way to track the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: E-Nose breath test
What this could lead to: If successful, this breath test could offer a simple, non-invasive way to monitor how well mesothelioma treatment is working, potentially reducing the need for frequent scans.
What could go wrong: This is a very small, early study with only 20 people. The breath test may not accurately reflect treatment response, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pleural mesothelioma Mesothelioma, Malignant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT PLEURAL MESOTHELIOMA

Contacts and locations

Locations

Memorial Sloan Kettering Basking Ridge (Consent Only)
RECRUITING

Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Bergen (Consent Only )
RECRUITING

Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITING

New York, New York, 10065, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only)
RECRUITING

Commack, New York, 11725, United States
Memorial Sloan Kettering Monmouth (Consent Only)
RECRUITING

Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Nassau (Consent Only)
RECRUITING

Uniondale, New York, 11553, United States
Memorial Sloan Kettering Westchester (Consent Only)
RECRUITING

Harrison, New York, 10604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.